Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma A Phase 2 Randomized Clinical Trial
Davendra P. S. Sohal et al.
JAMA ONCOLOGY (2021)
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
Federica Vernuccio et al.
DIAGNOSTICS (2021)
Pancreatic Adenocarcinoma, Version 2.2021
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
Akhil Chawla et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Quisette P. Janssen et al.
FRONTIERS IN ONCOLOGY (2020)
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
Valeria Merz et al.
CANCERS (2020)
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Paula Ghaneh et al.
ANNALS OF SURGERY (2019)
Impact of resection margin status on recurrence and survival in pancreatic cancer surgery
W. S. Tummers et al.
BRITISH JOURNAL OF SURGERY (2019)
Microvascular invasion is a major prognostic factor after pancreatico-duodenectomy for adenocarcinoma
Fabrizio Panaro et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship
Giulia Gasparini et al.
CANCERS (2019)
Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer - A Matched-Pair Analysis
Lea Timmermann et al.
ANTICANCER RESEARCH (2019)
Microscopic Venous Invasion in Pancreatic Cancer
Mihoko Yamada et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy
Marc Zins et al.
RADIOLOGY (2018)
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2018)
Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma
Jeffrey D. Epstein et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis
Stephan Schorn et al.
SURGICAL ONCOLOGY-OXFORD (2017)
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for Tand N Staging in Patients With Pancreatic Adenocarcinoma
Peter J. Allen et al.
ANNALS OF SURGERY (2017)
Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant
Burcu Saka et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
Cristina R. Ferrone et al.
ANNALS OF SURGERY (2015)
Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging
Olca Basturk et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The Impact of Neural Invasion Severity in Gastrointestinal Malignancies A Clinicopathological Study
Florian Liebl et al.
ANNALS OF SURGERY (2014)
Axon Guidance Factor SLIT2 Inhibits Neural Invasion and Metastasis in Pancreatic Cancer
Andreas Goehrig et al.
CANCER RESEARCH (2014)
Neuroplastic Changes Occur Early in the Development of Pancreatic Ductal Adenocarcinoma
Rachelle E. Stopczynski et al.
CANCER RESEARCH (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
Deyali Chatterjee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Microscopic Margins and Patterns of Treatment Failure in Resected Pancreatic Adenocarcinoma
Jennifer L. Gnerlich et al.
ARCHIVES OF SURGERY (2012)
Endoneurial Macrophages Induce Perineural Invasion of Pancreatic Cancer Cells by Secretion of GDNF and Activation of RET Tyrosine Kinase Receptor
Oren Cavel et al.
CANCER RESEARCH (2012)
Analysis of tumor-induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus
Peng Cheng et al.
CANCER SCIENCE (2012)
TNM Seventh Edition: What's New, What's Changed Communication From the International Union Against Cancer and the American Joint Committee on Cancer
Leslie H. Sobin et al.
CANCER (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Consensus transcriptome signature of perineural invasion in pancreatic carcinoma
Ivane Abiatari et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The nature of neural invasion by pancreatic cancer
Masato Kayahara et al.
PANCREAS (2007)
Share Paper
